Suppr超能文献

老年复杂多药治疗患者质子泵抑制剂的处方

Prescription of proton pump inhibitors in older adults with complex polytherapy.

机构信息

Dipartimento di Scienza e Tecnologia del Farmaco, Universita degli Studi di Torino, Torino, Italy

Dipartimento di Scienza e Tecnologia del Farmaco, Universita degli Studi di Torino, Torino, Italy.

出版信息

Eur J Hosp Pharm. 2020 Nov;27(6):341-345. doi: 10.1136/ejhpharm-2018-001697. Epub 2019 Mar 16.

Abstract

OBJECTIVES

Prescription of proton pump inhibitors (PPIs) may be a source of potentially clinically relevant drug-drug interactions (DDIs) and related complications for elderly patients with complex polytherapy at discharge from hospital. The aim of the study was to identify, through the analysis of hospital discharge records, the co-administrations (PPIs + one or more drugs potentially generating DDIs) hypothetically leading to severe consequences according to the literature and online databases. Subsequently, alternatives to PPIs were evaluated for the treatment of gastric acidity and ulcers.

METHODS

The medical records of 1288 patients, discharged from a geriatric ward at the Città della Salute e della Scienza Hospital in Turin from January 2012 to December 2013, were collected in an Excel database for analysis of DDIs using the literature and online sources such as Micromedex. RESULTS : Six hundred and sixty-three of the 1288 clinical folders had a PPI prescription. A list of 18 drugs considered potentially hazardous and able to trigger a DDI when co-administrated with PPIs was drafted; the frequencies of the co-prescriptions of each PPI with one of the listed drugs were esomeprazole 65.38%, lansoprazole 52.87%, omeprazole 48.19% and pantoprazole 37.11%. An analysis of these co-prescriptions, according to Micromedex classification, gave a percentage of major interactions of 11.01% over 663 clinical folders including a PPI.

CONCLUSIONS

This study provides a collection of potentially hazardous drug associations and helpful suggestions to improve the quality of prescriptions for elderly patients and strengthens the case for synergic work between doctors and pharmacists in the wards.

摘要

目的

质子泵抑制剂 (PPI) 的处方可能是医院出院后接受复杂多药物治疗的老年患者潜在临床相关药物-药物相互作用 (DDI) 和相关并发症的来源。本研究的目的是通过分析医院出院记录,根据文献和在线数据库,确定假设会导致严重后果的联合用药(PPI + 一种或多种可能产生 DDI 的药物)。随后,评估了 PPI 的替代品用于治疗胃酸和溃疡。

方法

从 2012 年 1 月至 2013 年 12 月,在都灵的 Città della Salute e della Scienza 医院老年病房出院的 1288 名患者的病历被收集到 Excel 数据库中,使用文献和在线资源(如 Micromedex)分析 DDI。

结果

1288 份临床文件夹中有 663 份有 PPI 处方。制定了一份潜在危险药物清单,当与 PPI 联合使用时,这些药物可能会引发 DDI;列出了每种 PPI 与列出药物之一的联合处方频率,艾司奥美拉唑为 65.38%、兰索拉唑为 52.87%、奥美拉唑为 48.19%、泮托拉唑为 37.11%。根据 Micromedex 分类,对这些联合处方进行分析,在包括 PPI 的 663 份临床文件夹中,主要相互作用的百分比为 11.01%。

结论

本研究提供了一组潜在危险的药物组合,并提出了有助于改善老年患者处方质量的建议,并加强了医生和药剂师在病房协同工作的理由。

相似文献

1
Prescription of proton pump inhibitors in older adults with complex polytherapy.
Eur J Hosp Pharm. 2020 Nov;27(6):341-345. doi: 10.1136/ejhpharm-2018-001697. Epub 2019 Mar 16.
2
Agreement of Different Drug-Drug Interaction Checkers for Proton Pump Inhibitors.
JAMA Netw Open. 2024 Jul 1;7(7):e2419851. doi: 10.1001/jamanetworkopen.2024.19851.
3
Proton pump inhibitor co-prescription with dual antiplatelet therapy among patients with acute coronary syndrome in Qatar.
Int J Clin Pharm. 2016 Apr;38(2):353-61. doi: 10.1007/s11096-016-0250-4. Epub 2016 Jan 9.
5
Adverse drug reactions due to drug-drug interactions with proton pump inhibitors: assessment of systematic reviews with AMSTAR method.
Expert Opin Drug Saf. 2016;15(2):223-36. doi: 10.1517/14740338.2016.1128413. Epub 2016 Jan 5.
6
Interaction risk with proton pump inhibitors in general practice: significant disagreement between different drug-related information sources.
Br J Clin Pharmacol. 2006 Nov;62(5):582-90. doi: 10.1111/j.1365-2125.2006.02687.x. Epub 2006 Jul 6.
7
Pharmacokinetic drug interaction profiles of proton pump inhibitors: an update.
Drug Saf. 2014 Apr;37(4):201-11. doi: 10.1007/s40264-014-0144-0.
8
Influence of different proton pump inhibitors on the pharmacokinetics of voriconazole.
Int J Antimicrob Agents. 2017 Apr;49(4):403-409. doi: 10.1016/j.ijantimicag.2016.11.025. Epub 2017 Jan 31.
9
Drug-drug interaction profiles of proton pump inhibitors.
Clin Pharmacokinet. 2010 Aug;49(8):509-33. doi: 10.2165/11531320-000000000-00000.

引用本文的文献

1
Associations of high-risk drug patterns with mortality among community-dwelling older adults: A 23-year prospective cohort study.
PLoS One. 2025 Sep 11;20(9):e0332210. doi: 10.1371/journal.pone.0332210. eCollection 2025.
3
Pharmacodynamics, pharmacokinetics, interactions with other drugs, toxicity and clinical effectiveness of proton pump inhibitors.
Front Pharmacol. 2025 Jul 23;16:1507812. doi: 10.3389/fphar.2025.1507812. eCollection 2025.
8
Medication-related factors associated with proton pump inhibitor prescription beyond official guidelines in older adults.
Eur Geriatr Med. 2020 Dec;11(6):1051-1061. doi: 10.1007/s41999-020-00380-5. Epub 2020 Aug 17.

本文引用的文献

4
A comparative study of QT prolongation with serotonin reuptake inhibitors.
Psychopharmacology (Berl). 2017 Oct;234(20):3075-3081. doi: 10.1007/s00213-017-4685-7. Epub 2017 Aug 3.
6
We Are Using Too Many PPIs, and We Need to Stop: A European Perspective.
Am J Gastroenterol. 2016 Aug;111(8):1085-6. doi: 10.1038/ajg.2016.166. Epub 2016 May 10.
7
American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults.
J Am Geriatr Soc. 2015 Nov;63(11):2227-46. doi: 10.1111/jgs.13702. Epub 2015 Oct 8.
8
Proton pump inhibitors utilisation in older people in New Zealand from 2005 to 2013.
Intern Med J. 2015 Jun;45(6):624-9. doi: 10.1111/imj.12757.
9
Proton pump inhibitors and hypomagnesemia in polymorbid elderly adults.
J Am Geriatr Soc. 2015 Jan;63(1):179-80. doi: 10.1111/jgs.13212.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验